According to the statistics of Reportlinker.com, the global market of advanced wound care products will grow at a CAGR of 6.5% and will reach 13.944 billion by 2026. To date, there have been no effective drugs or medical devices for the treatment of chronic wounds. Read More
Oneness Listed in the S&P Global Sustainability Yearbook for the Third Consecutive Year, Ranking Among the Top 10 in the Global "Pharmaceuticals Industry" for 2025Read More
Oneness has received notification from the Notified Body, confirming that we comply with the MDSAP (Medical Device Single Audit Program) quality management system standards. The MDSAP certificate has been issued with the certificate number: MDSAP 803792Read More
Oneness Biotech Co., Ltd., had been granted with MDSAP (Medical Device Single Audit Program) certification for medical device quality management system.Read More
U.S. FDA notified Oneness today that Bonvadis® for partial thickness wounds, closed post-surgical wounds, and burns (1st and superficial 2nd degrees) is 510(k) cleared.Read More
